Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T84780 | Target Info | |||
Target Name | Cellular inhibitor of apoptosis 1 (BIRC2) | ||||
Synonyms | hIAP2; hIAP-2; TNFR2TRAFsignaling complex protein 2; TNFR2-TRAF-signaling complex protein 2; RNF48; RING-type E3 ubiquitin transferase BIRC2; RING finger protein 48; MIHB; Inhibitor of apoptosis protein 2; IAP2; IAP homolog B; CIAP1; C-IAP1; Baculoviral IAP repeatcontaining protein 2; Baculoviral IAP repeat-containing protein 2; API1 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BIRC2 | ||||
Biochemical Class | Acyltransferase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 2 Acid anhydride hydrolases | + | |||
Interacting Target Name | Ras-related C3 botulinum toxin substrate 1 (RAC1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TC25; Ras-like protein TC25; p21-Rac1; MIG5; Cell migration-inducing gene5 protein; Cell migration-inducing gene 5 protein | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [1] | |||
2 | Affinity Capture-Western | [1] | |||
3 | Biochemical Activity | [2] | |||
4 | Reconstituted Complex | [3] | |||
Interacting Protein Name | Cell division control protein 42 homolog (CDC42) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDC42Hs; G25K | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [4] | |||
2 | Reconstituted Complex | [3] | |||
Acyltransferases | [+] 3 Acyltransferases | + | |||
Interacting Protein Name | TNF receptor-associated factor 2 (TRAF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MGC:45012; TRAP; TRAP3 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Affinity Capture-Western | [7] | |||
4 | Affinity Capture-Western | [8] | |||
5 | Affinity Capture-Western | [9] | |||
6 | Affinity Capture-Western | [10] | |||
7 | Affinity Capture-Western | [11] | |||
8 | Affinity Capture-Western | [12] | |||
9 | Affinity Capture-Western | [13] | |||
10 | Affinity Capture-Western | [14] | |||
11 | Affinity Capture-Western | [15] | |||
12 | Biochemical Activity | [6] | |||
13 | Biochemical Activity | [16] | |||
14 | Biochemical Activity | [17] | |||
15 | Co-localization | [18] | |||
16 | Reconstituted Complex | [6] | |||
17 | Reconstituted Complex | [19] | |||
18 | Reconstituted Complex | [20] | |||
19 | Reconstituted Complex | [3] | |||
20 | Reconstituted Complex | [8] | |||
Interacting Target Name | X-linked inhibitor of apoptosis protein (XIAP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | X-linked IAP; Xlinked IAP; RING-type E3 ubiquitin transferase XIAP; Inhibitor of apoptosis protein 3; ILP; IAP-like protein; IAPlike protein; IAP-3; IAP3; hILP; hIAP-3; hIAP3; E3 ubiquitin-protein ligase XIAP; E3 ubiquitinprotein ligase XIAP; BIRC4; Baculoviral IAP repeat-containing protein 4; Baculoviral IAP repeatcontaining protein 4; API3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [13] | |||
3 | Affinity Capture-Western | [22] | |||
Interacting Target Name | Melanoma inhibitor of apoptosis protein (ML-IAP) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | UNQ5800/PRO19607/PRO21344; RNF50; RING-type E3 ubiquitin transferase BIRC7; RING finger protein 50; MLIAP; Livin; Kidney inhibitor of apoptosis protein; KIAP; Baculoviral IAP repeat-containing protein 7 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [23] | |||
3 | Yeast two hybrid | [24] | |||
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Protein Name | TNF receptor-associated factor 1 (TRAF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EBI6; MGC:10353 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-MS | [5] | |||
3 | Affinity Capture-Western | [11] | |||
4 | Reconstituted Complex | [6] | |||
5 | Reconstituted Complex | [19] | |||
6 | Reconstituted Complex | [20] | |||
7 | Yeast two hybrid | [25] | |||
8 | Yeast two hybrid | [26] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Endoplasmin (HSP90B1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor rejection antigen 1; TRA1; Heat shock protein 90 kDa beta member 1; GRP-94; GRP94; gp96 homolog; 94 kDa glucose-regulated protein; 94 kDa glucoseregulated protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [27] | |||
2 | Fluorescence Resonance Energy Transfer | [27] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | Receptor-interacting protein 1 (RIPK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RIP-1; RIP1; RIP; Receptor-interacting serine/threonine-protein kinase 1; Cell death protein RIP | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Affinity Capture-Western | [29] | |||
3 | Affinity Capture-Western | [30] | |||
4 | Affinity Capture-Western | [31] | |||
5 | Biochemical Activity | [32] | |||
6 | Biochemical Activity | [24] | |||
7 | Biochemical Activity | [33] | |||
8 | Biochemical Activity | [30] | |||
9 | Biochemical Activity | [29] | |||
10 | Reconstituted Complex | [29] | |||
Interacting Protein Name | Receptor-interacting protein 2 (RIP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | UNQ277/PRO314/PRO34092; Tyrosine-protein kinase RIPK2; RIP-like-interacting CLARP kinase; RIP-2; RIP2; RICK; Receptor-interacting serine/threonine-protein kinase 2; Receptor-interacting protein 2; CARDIAK; CARD-containing interleukin-1 beta-converting enzyme-associated kinase; CARD-containing IL-1 beta ICE-kinase | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Affinity Capture-Western | [29] | |||
3 | Affinity Capture-Western | [35] | |||
4 | Biochemical Activity | [29] | |||
5 | Reconstituted Complex | [35] | |||
6 | Reconstituted Complex | [29] | |||
7 | Reconstituted Complex | [36] | |||
Peptidases | [+] 4 Peptidases | + | |||
Interacting Target Name | Caspase-9 (CASP9) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MCH6; ICE-like apoptotic protease 6; ICE-LAP6; CASP-9; Apoptotic protease-activating factor 3; Apoptotic protease Mch-6; Apoptotic protease activating factor 3; APAF-3 | ||||
Evidence Score (E-score) | 11 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [37] | |||
2 | Affinity Capture-Western | [38] | |||
3 | Affinity Capture-Western | [39] | |||
4 | Affinity Capture-Western | [40] | |||
5 | Affinity Capture-Western | [30] | |||
6 | Co-crystal Structure | [41] | |||
7 | Co-localization | [18] | |||
8 | Protein-peptide | [41] | |||
9 | Reconstituted Complex | [37] | |||
10 | Reconstituted Complex | [42] | |||
11 | Yeast two hybrid | [43] | |||
Interacting Target Name | Caspase-7 (CASP7) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MCH3; ICE-like apoptotic protease 3; ICE-LAP3; CMH-1; CASP-7; Apoptotic protease Mch-3 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [44] | |||
2 | Affinity Capture-Western | [38] | |||
3 | Affinity Capture-Western | [39] | |||
4 | Biochemical Activity | [45] | |||
5 | Reconstituted Complex | [45] | |||
6 | Reconstituted Complex | [20] | |||
Interacting Target Name | Caspase-3 (CASP3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Yama protein; SREBP cleavage activity 1; SCA-1; Protein Yama; Cysteine protease CPP32; CPP-32; CPP32; Caspase 3; CASP-3; Apopain | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Biochemical Activity | [45] | |||
3 | Reconstituted Complex | [45] | |||
4 | Reconstituted Complex | [20] | |||
Interacting Protein Name | High temperature requirement protein A2 (HTRA2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | OMI; PARK13; PRSS25 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [46] | |||
2 | Affinity Capture-MS | [21] | |||
3 | Affinity Capture-Western | [47] | |||
4 | Affinity Capture-Western | [48] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Target Name | E2F transcription factor 1 (E2F1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor E2F1; Retinoblastoma-binding protein 3; Retinoblastoma-associated protein 1; RBBP-3; RBBP3; RBAP-1; pRB-binding protein E2F-1; PBR3; E2F-1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [49] | |||
2 | Affinity Capture-Western | [10] | |||
3 | Biochemical Activity | [49] | |||
4 | Reconstituted Complex | [49] | |||
Ubiquitin related proteins | [+] 6 Ubiquitin related proteins | + | |||
Interacting Protein Name | Ubiquitin-conjugating enzyme E2 D1 (UBE2D1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E2(17)KB1; SFT; UBC4/5; UBCH5; UBCH5A | ||||
Evidence Score (E-score) | 12 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [50] | |||
2 | Reconstituted Complex | [32] | |||
3 | Reconstituted Complex | [24] | |||
4 | Reconstituted Complex | [51] | |||
5 | Reconstituted Complex | [52] | |||
6 | Reconstituted Complex | [53] | |||
7 | Reconstituted Complex | [30] | |||
8 | Reconstituted Complex | [49] | |||
9 | Reconstituted Complex | [2] | |||
10 | Reconstituted Complex | [29] | |||
11 | Reconstituted Complex | [54] | |||
12 | Yeast two hybrid | [24] | |||
Interacting Target Name | Polyubiquitin-C (UBC) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMG20; ubiquitin C | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Biochemical Activity | [55] | |||
2 | Reconstituted Complex | [56] | |||
3 | Reconstituted Complex | [24] | |||
4 | Reconstituted Complex | [57] | |||
Interacting Protein Name | Ubiquitin-conjugating enzyme E2 D2 (UBE2D2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E2(17)KB2; PUBC1; UBC4; UBC4/5; UBCH4; UBCH5B | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Reconstituted Complex | [58] | |||
2 | Reconstituted Complex | [6] | |||
3 | Reconstituted Complex | [45] | |||
4 | Yeast two hybrid | [24] | |||
Interacting Protein Name | Ubiquitin-conjugating enzyme E2 D3 (UBE2D3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E2(17)KB3; UBC4/5; UBCH5C | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [50] | |||
2 | Reconstituted Complex | [50] | |||
3 | Yeast two hybrid | [24] | |||
Interacting Protein Name | Ubiquitin-conjugating enzyme E2 J1 (UBE2J1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HSPC153; HSPC205; HSU93243; NCUBE.1; NCUBE1; UBC6; Ubc6p | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [59] | |||
2 | Reconstituted Complex | [14] | |||
Interacting Protein Name | Ubiquitin-conjugating enzyme E2 S (UBE2S) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E2.EPF; E2EPF; EPF5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [51] | |||
2 | Yeast two hybrid | [24] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Target Name | Direct IAP-binding protein with low pI (DIABLO) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Smac protein; Smac; Second mitochondria-derived activator of caspase; Direct IAP binding protein with low pI; Diablo homolog, mitochondrial | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [46] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [50] | |||
4 | Affinity Capture-Western | [9] | |||
5 | Affinity Capture-Western | [60] | |||
6 | Biochemical Activity | [61] | |||
7 | Biochemical Activity | [50] | |||
8 | Co-crystal Structure | [41] | |||
9 | Protein-peptide | [41] | |||
10 | Reconstituted Complex | [62] | |||
Interacting Target Name | Apoptosis inhibitor survivin (BIRC5) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Survivin; IAP4; Baculoviral IAP repeat-containing protein 5; Apoptosis inhibitor survivin; Apoptosis inhibitor 4; API4 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [63] | |||
2 | Reconstituted Complex | [64] | |||
3 | Reconstituted Complex | [63] | |||
4 | Reconstituted Complex | [65] | |||
Interacting Protein Name | NF-kappa-B essential modulator (IKBKG) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AMCBX1; FIP.3; FIP3; Fip3p; IKK.gamma; IMD33; IP; IP1; IP2; IPD2; NEMO; ZC2HC9 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-Western | [66] | |||
3 | Affinity Capture-Western | [67] | |||
4 | Biochemical Activity | [68] | |||
Interacting Target Name | Tumor necrosis factor (TNF) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour necrosis factor alpha; Tumour necrosis factor; Tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor; TNFSF2; TNF-alpha; TNFalpha; TNF-a; TNFA; TNF alpha; Cachectin | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [69] | |||
2 | Affinity Capture-Western | [70] | |||
Interacting Target Name | CD40L receptor (CD40) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor necrosis factor receptor superfamily member 5; TNFRSF5; CDw40; CD40L receptor; Bp50; B-cell surfaceantigen CD40; B-cell surface antigen CD40 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [71] | |||
2 | Affinity Capture-Western | [72] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | AMPylation of Rho GTPases subverts multiple host signaling processes. J Biol Chem. 2014 Nov 21;289(47):32977-88. | ||||
REF 2 | IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. EMBO J. 2012 Jan 4;31(1):14-28. | ||||
REF 3 | cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation. Oncogene. 2014 Nov 27;33(48):5534-45. | ||||
REF 4 | Ubiquitin-dependent regulation of Cdc42 by XIAP. Cell Death Dis. 2017 Jun 29;8(6):e2900. | ||||
REF 5 | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. EMBO J. 2013 Apr 17;32(8):1103-14. | ||||
REF 6 | TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature. 2002 Mar 21;416(6878):345-7. | ||||
REF 7 | Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell Death Differ. 2011 Aug;18(8):1376-86. | ||||
REF 8 | Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J Biol Chem. 2006 Jan 13;281(2):1080-90. | ||||
REF 9 | Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2. J Biol Chem. 2009 Jul 31;284(31):20531-9. | ||||
REF 10 | Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription. J Biol Chem. 2011 Jul 29;286(30):26406-17. | ||||
REF 11 | The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2. J Biol Chem. 2006 Sep 29;281(39):29022-9. | ||||
REF 12 | Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein. J Biol Chem. 2000 Apr 14;275(15):11114-20. | ||||
REF 13 | Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16182-7. | ||||
REF 14 | TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J. 2005 May 18;24(10):1886-98. | ||||
REF 15 | Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor B (NF-B) signaling. J Biol Chem. 2015 Apr 17;290(16):10395-405. | ||||
REF 16 | IB kinase phosphorylates TRAF2 to promote mammary epithelial cell transformation. Mol Cell Biol. 2012 Dec;32(23):4756-68. | ||||
REF 17 | TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ. 2015 Nov;22(11):1846-57. | ||||
REF 18 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 19 | Asymmetric recruitment of cIAPs by TRAF2. J Mol Biol. 2010 Jul 2;400(1):8-15. | ||||
REF 20 | The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 1997 Dec 1;16(23):6914-25. | ||||
REF 21 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 22 | IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells. PLoS Pathog. 2006 Oct;2(10):e114. | ||||
REF 23 | Role of melanoma inhibitor of apoptosis (ML-IAP) protein, a member of the baculoviral IAP repeat (BIR) domain family, in the regulation of C-RAF kinase and cell migration. J Biol Chem. 2012 Aug 17;287(34):28445-55. | ||||
REF 24 | c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 2010 Dec 15;29(24):4198-209. | ||||
REF 25 | The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 1995 Dec 29;83(7):1243-52. | ||||
REF 26 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 27 | Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell differentiation. Cell Death Differ. 2008 May;15(5):859-66. | ||||
REF 28 | Parkin regulates NF-B by mediating site-specific ubiquitination of RIPK1. Cell Death Dis. 2018 Jun 28;9(7):732. | ||||
REF 29 | cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). PLoS One. 2011;6(9):e22356. | ||||
REF 30 | Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-B and Lung Tumorigenesis. Cancer Res. 2016 May 15;76(10):2977-89. | ||||
REF 31 | Opposing effect of EGFRWT on EGFRvIII-mediated NF-B activation with RIP1 as a cell death switch. Cell Rep. 2013 Aug 29;4(4):764-75. | ||||
REF 32 | A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol Cell. 2009 Oct 23;36(2):302-14. | ||||
REF 33 | cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 2008 Jun 20;30(6):689-700. | ||||
REF 34 | Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol. 1998 Jul 16;8(15):885-8. | ||||
REF 35 | Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity. 2009 Jun 19;30(6):789-801. | ||||
REF 36 | Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling. EMBO J. 2018 Sep 3;37(17). pii: e99372. | ||||
REF 37 | IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998 Apr 15;17(8):2215-23. | ||||
REF 38 | The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem. 2006 Feb 10;281(6):3254-60. | ||||
REF 39 | ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol. 2000 Nov 2;10(21):1359-66. | ||||
REF 40 | Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6170-5. | ||||
REF 41 | The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9. Acta Crystallogr D Biol Crystallogr. 2009 Jan;65(Pt 1):58-66. | ||||
REF 42 | Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp Cell Res. 2006 Jul 15;312(12):2347-57. | ||||
REF 43 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 44 | IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Nat Cell Biol. 2005 Jan;7(1):70-7. | ||||
REF 45 | The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J Biol Chem. 2009 May 8;284(19):12772-82. | ||||
REF 46 | The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J Biol Chem. 2003 Oct 3;278(40):38699-706. | ||||
REF 47 | A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 2001 Sep;8(3):613-21. | ||||
REF 48 | HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem. 2002 Jan 4;277(1):445-54. | ||||
REF 49 | DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues. Cell Death Dis. 2017 May 25;8(5):e2816. | ||||
REF 50 | Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J Biol Chem. 2003 Mar 21;278(12):10055-60. | ||||
REF 51 | Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals. Mol Cell Proteomics. 2011 May;10(5):M110.003756. | ||||
REF 52 | Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1. EMBO J. 2014 Aug 18;33(16):1784-801. | ||||
REF 53 | Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J. 2015 Feb 3;34(3):307-25. | ||||
REF 54 | Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity. PLoS One. 2014 Mar 14;9(3):e92124. | ||||
REF 55 | Gliotoxin suppresses NF-B activation by selectively inhibiting linear ubiquitin chain assembly complex (LUBAC). ACS Chem Biol. 2015 Mar 20;10(3):675-81. | ||||
REF 56 | IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat Cell Biol. 2008 Nov;10(11):1309-17. | ||||
REF 57 | Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 2009 May;10(5):466-73. | ||||
REF 58 | Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J Biol Chem. 2011 May 13;286(19):17015-28. | ||||
REF 59 | The role of ubiquitin-conjugating enzyme Ube2j1 phosphorylation and its degradation by proteasome during endoplasmic stress recovery. J Cell Commun Signal. 2017 Sep;11(3):265-273. | ||||
REF 60 | Nuclear factor-B-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1). J Biol Chem. 2014 Oct 31;289(44):30680-9. | ||||
REF 61 | The ubiquitin-associated domain of cellular inhibitor of apoptosis proteins facilitates ubiquitylation. J Biol Chem. 2014 Sep 12;289(37):25721-36. | ||||
REF 62 | Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J Biol Chem. 2004 Apr 23;279(17):16963-70. | ||||
REF 63 | Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cells. J Biol Chem. 2015 Apr 17;290(16):9974-85. | ||||
REF 64 | An IAP-IAP complex inhibits apoptosis. J Biol Chem. 2004 Aug 13;279(33):34087-90. | ||||
REF 65 | cIAP1 Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res. 2005 Jan 1;65(1):210-8. | ||||
REF 66 | A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem. 2003 Sep 26;278(39):37297-305. | ||||
REF 67 | A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-B activation. Mol Cell. 2010 Oct 8;40(1):63-74. | ||||
REF 68 | p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO. Nat Commun. 2012;3:1061. | ||||
REF 69 | Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell. 2009 Dec 11;36(5):831-44. | ||||
REF 70 | The seventh zinc finger motif of A20 is required for the suppression of TNF--induced apoptosis. FEBS Lett. 2015 May 22;589(12):1369-75. | ||||
REF 71 | HOIL-1L interacting protein (HOIP) as an NF-kappaB regulating component of the CD40 signaling complex. PLoS One. 2010 Jun 30;5(6):e11380. | ||||
REF 72 | Molecular characterization of CD40 signaling intermediates. J Biol Chem. 2001 Nov 16;276(46):43334-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.